Cy­to­ki­net­ics

CEO Robert I. Blum
CEO Robert I. Blum
USA | Funding: $1.8B (+)

Website: https://cytokinetics.com/

Cytokinetics develops first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised.